Ascension Capital Advisors Inc. Buys Shares of 9,158 SPDR S&P Biotech ETF $XBI

Ascension Capital Advisors Inc. bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 9,158 shares of the exchange traded fund’s stock, valued at approximately $1,117,000. SPDR S&P Biotech ETF comprises about 0.4% of Ascension Capital Advisors Inc.’s holdings, making the stock its 27th biggest position.

A number of other large investors have also recently bought and sold shares of XBI. AQR Capital Management LLC grew its holdings in SPDR S&P Biotech ETF by 77.1% during the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares during the last quarter. Marshall Wace LLP grew its holdings in SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after buying an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at $260,000. Ameriprise Financial Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.7% during the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after purchasing an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.5%

Shares of SPDR S&P Biotech ETF stock opened at $136.69 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $78.06 and a fifty-two week high of $139.19. The firm has a market cap of $8.72 billion, a PE ratio of 11.47 and a beta of 0.85. The business’s fifty day moving average is $130.99 and its two-hundred day moving average is $125.94.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.